after ex parte appeal
on 23 Jan 2023
Last Applicant/ Owned by
Cambridge CB24 9BZ
GB
Serial Number
79266020 filed on 17th Jul 2019
Registration Number
N/A
Correspondent Address
MICHAEL T OLSEN
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Pharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement Read More
Pharmaceutical and veterinary preparations, namely, for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pharmaceutical preparations for the treatment of neurological conditions and diseases; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions, each of the foregoing for use in treating pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, spasticity, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; pure extracts of medicinal plants and herbs for pharmaceutical use; foodstuffs for medicinal purposes; herb teas for medicinal purposes; pharmaceutical preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; plant extracts for pharmaceutical purposes
No 79266020
No Service/Collective Mark
No
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
11th Mar 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
12th Feb 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
10th Feb 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
10th Feb 2023 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL |
23rd Jan 2023 | EXPARTE APPEAL TERMINATED |
23rd Jan 2023 | ABANDONMENT - AFTER EX PARTE APPEAL |
05th Jan 2023 | INTERNATIONAL REGISTRATION RENEWED |
09th Dec 2022 | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF |
17th Aug 2022 | SUBSEQUENT FINAL REFUSAL WRITTEN |
17th Aug 2022 | SUBSEQUENT FINAL EMAILED |